Primary Article

Aspirin Administration for Cardiac‐related Acute Chest Pain/Angina Increased Use in Medicare Patients

Authors: MARK BING MD, MPH, ROBERT L. ABEL PhD, PETER PENDERGRASS MD, MPH, MINNIE MALONE RN, KAREN SABHARWAL MPH, CAROL McCAULEY RRA

Abstract

Abstract Background. Coronary heart disease (CHD), the leading cause of death in the United States, accounted for approximately 490,000 deaths in 1993. Angina pectoris, a manifestation of CHD, accounted for 13,586 Medicare discharges in 1993 in Texas. A pilot project showed aspirin prophylaxis that reduces cardiovascular morbidity and mortality in individuals with acute angina is underused. Texas Medical Foundation collaborated with 10 acute‐care facilities to improve aspirin prophylaxis. Methods. Collaborators assessed processes of care and implemented clinical pathways to improve aspirin administration. Data were abstracted from medical records before and after pathway implementation to evaluate impact. Results. Aspirin administration during hospital stay increased 10.8%, aspirin administration on discharge increased 11.7%, and average time from arrival to aspirin administration decreased 2.9 hours. Conclusions. Results suggest collaborator‐implemented clinical pathways significantly improved care received by Medicare patients admitted for cardiac‐related acute chest pain/angina. Data suggest room for further improvement.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References